Key Market Indicators
The market for antidepressant medication in Estonia is projected to hit $5.5 million by 2028, up from $5.4 million in 2023, marking an average annual growth rate of 0.4%. Since 2004, the Estonian antidepressant market has seen a steady increase, with an average yearly growth rate of 4.7%. In the current year, Estonia ranks 16th globally in this sector, just behind Iceland, which has taken the 15th spot with sales of $5.4 million. Leading the global rankings are Spain, Italy, and Australia, occupying the second, third, and fourth positions respectively.
